Diseased Saphenous Vein Grafts (DBCOND0051081)

Identifiers

Synonyms

Saphenous Vein Graft Disease

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01307553	Over and Under/Aneugraft Pericardium Covered Stent Long Term Follow up Registry	No drug interventions	Not Available	Not Available	unknown_status
NCT02053909	Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis	Acetylsalicylic acid Ticagrelor	prevention	4	completed
NCT01528709	Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)	Atorvastatin	prevention	3	completed
NCT00264706	PolyArginine Treated vEiN grafTs (PATENT)	Nona-arginine	treatment	1 / 2	terminated
NCT00453518	The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts	No drug interventions	treatment	Not Available	completed
NCT00263263	RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.	No drug interventions	treatment	2	completed
NCT01042444	Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft	No drug interventions	treatment	Not Available	terminated
NCT03175952	Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.	No drug interventions	Not Available	Not Available	unknown_status
NCT01036048	A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease	No drug interventions	Not Available	Not Available	completed